title: Rationalizing prescribing for oral and oesophageal candidiasis.
authors.affiliation: Department of Genitourinary Medicine, King's Healthcare, London, UK.
authors.forename: C B
authors.initials: CB
authors.lastname: Taylor
authors.forename: R
authors.initials: R
authors.lastname: Finlay
authors.forename: C
authors.initials: C
authors.lastname: Richardson
authors.forename: P
authors.initials: P
authors.lastname: Bunting
authors.forename: J
authors.initials: J
authors.lastname: Welch
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000935:Antifungal Agents / Q000191:economics / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy*; D002180:Candidiasis, Oral / Q000188:drug therapy*; D016527:Drug Costs; D004935:Esophageal Diseases / Q000188:drug therapy*; D015725:Fluconazole / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D007654:Ketoconazole / Q000191:economics / Q000627:therapeutic use; D008485:Medical Audit; D017410:Practice Guidelines as Topic; D012189:Retrospective Studies
chemical_list: D000935:Antifungal Agents; D015725:Fluconazole; D007654:Ketoconazole